81 FR 89943 - Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
FEDERAL TRADE COMMISSION Federal Register Volume 81, Issue 239 (December 13, 2016)
Federal Register Volume 81, Issue 239 (December 13, 2016)
| Page Range | 89943-89946 | |
| FR Document | 2016-29771 |
[Federal Register Volume 81, Number 239 (Tuesday, December 13, 2016)] [Notices] [Pages 89943-89946] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-29771] ======================================================================= ----------------------------------------------------------------------- FEDERAL TRADE COMMISSION Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the [[Page 89944]] Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans. Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its expiration and requires that notice of this action be published in the Federal Register. The following transactions were granted early termination--on the dates indicated--of the waiting period provided by law and the premerger notification rules. The listing for each transaction includes the transaction number and the parties to the transaction. The grants were made by the Federal Trade Commission and the Assistant Attorney General for the Antitrust Division of the Department of Justice. Neither agency intends to take any action with respect to these proposed acquisitions during the applicable waiting period. Early Terminations Granted November 1, 2016 Thru November 30, 2016 ------------------------------------------------------------------------ ------------------------------------------------------------------------ 11/01/2016 ------------------------------------------------------------------------ 20170004.................. G Sofina s.a.; BCP CC Holdings L.P.; Sofina s.a. 20170060.................. G Roche Holding Ltd; Hanmi Pharmaceutical Co., Ltd.; Roche Holding Ltd 20170110.................. G Wellspring Capital Partners V, L.P.; MM Hoffmaster Holdings L.P.; Wellspring Capital Partners V, L.P. ------------------------------------------------------------------------ 11/02/2016 ------------------------------------------------------------------------ 20161726.................. G Berry Plastics Group, Inc.; AEP Industries Inc.; Berry Plastics Group, Inc. 20170008.................. G Tech Data Corporation; Avnet, Inc.; Tech Data Corporation. 20170013.................. G B&G Foods, Inc.; The Garfield Weston Charitable Foundation; B&G Foods, Inc. 20170114.................. G RHI AG; Magnesita Refratarios S.A.; RHI AG. ------------------------------------------------------------------------ 11/03/2016 ------------------------------------------------------------------------ 20170104.................. G Tenex Capital Partners II, L.P.; Pugh Oil Company, Inc.; Tenex Capital Partners II, L.P. ------------------------------------------------------------------------ 11/04/2016 ------------------------------------------------------------------------ 20170026.................. G Francisco Partners IV, L.P.; Eric and Amy Huang Legacy Trust u/a 9/30/11; Francisco Partners IV, L.P. 20170027.................. G Francisco Partners IV, L.P.; Amy B. Huang Legacy Trust u/ a 2/1/12; Francisco Partners IV, L.P. 20170084.................. G Equistone V FPCI; Wayzata Opportunities Fund II, L.P.; Equistone V FPCI. 20170117.................. G Comvest Investment Partners V, L.P.; Lasko Group, Inc.; Comvest Investment Partners V, L.P. 20170118.................. G Acrisure Investors FO, LLC; Genstar Capital Partners VI, L.P.; Acrisure Investors FO, LLC. 20170124.................. G Onex Partners IV LP; Supervalu Inc.; Onex Partners IV LP. 20170125.................. G Wynnchurch Capital Partners IV, L.P.; Rosboro, LLC; Wynnchurch Capital Partners IV, L.P. 20170126.................. G Kayne Anderson Energy Fund VI, L.P.; RSP Permian, Inc.; Kayne Anderson Energy Fund VI, L.P. 20170127.................. G Kayne Anderson Energy Fund VII, L.P.; RSP Permian, Inc.; Kayne Anderson Energy Fund VII, L.P. 20170132.................. G Nationwide Mutual Insurance Company; JNF Investors LLC; Nationwide Mutual Insurance Company. 20170135.................. G Carlyle Partners VI Cayman, L.P.; Total S.A.; Carlyle Partners VI Cayman, L.P. 20170138.................. G ITOCHU Corporation; Empire Gen Holdings, Inc.; ITOCHU Corporation. 20170145.................. G Unibel; White Knight VIII FPCI; Unibel. ------------------------------------------------------------------------ 11/07/2016 ------------------------------------------------------------------------ 20170035.................. G Warburg Pincus Private Equity XII, L.P.; Ascentium Capital LLC; Warburg Pincus Private Equity XII, L.P. 20170039.................. G Hanwha General Chemical Co., Ltd.; Hanwha Q Cells Korea Corp.; Hanwha General Chemical Co., Ltd. 20170071.................. G Allergan plc; AstraZeneca PLC; Allergan plc. 20170115.................. G Verizon Communications Inc.; AT&T Inc.; Verizon Communications Inc. 20170116.................. G AT&T Inc.; Verizon Communications Inc.; AT&T Inc. 20170123.................. G Novartis AG; Selexys Pharmaceuticals Corporation; Novartis AG. 20170147.................. G Hainan Cihang Charitable Foundation; CIT Group Inc.; Hainan Cihang Charitable Foundation. 20170157.................. G H.I.G. Middle Market LBO Fund II, L.P.; Mercury Capital, L.P.; H.I.G. Middle Market LBO Fund II, L.P. ------------------------------------------------------------------------ 11/08/2016 ------------------------------------------------------------------------ 20170085.................. G Endeavour Capital Fund VII, L.P.; OFD Holdco, Inc.; Endeavour Capital Fund VII, L.P. 20170130.................. G Oaktree Principal Fund VI, L.P.; SunOpta, Inc.; Oaktree Principal Fund VI, L.P. 20170142.................. G AEA Investors Fund VI LP; CHS Private Equity V L.P.; AEA Investors Fund VI LP. ------------------------------------------------------------------------ 11/10/2016 ------------------------------------------------------------------------ 20161294.................. G Promotora de Inversiones Mexicanas, S.A.; CEMEX S.A.B. de C.V.; Promotora de Inversiones Mexicanas, S.A. 20170152.................. G Platte River Equity III, L.P.; H. J. Baker & Bro., Inc.; Platte River Equity III, LP. ------------------------------------------------------------------------ 11/14/2016 ------------------------------------------------------------------------ 20170119.................. G HKW Capital Partners IV, L.P.; Xirgo Technologies, Inc.; HKW Capital Partners IV, L.P. 20170133.................. G j2 Global, Inc.; Everyday Health, Inc.; j2 Global, Inc. ------------------------------------------------------------------------ 11/15/2016 ------------------------------------------------------------------------ 20160836.................. G Verizon Communications Inc.; Carl C. Icahn; Verizon Communications Inc. [[Page 89945]] 20170153.................. G Mitsubishi Materials Corporation; Nordic Capital V, L.P.; Mitsubishi Materials Corporation. 20170154.................. G CONSOL Energy Inc.; Noble Energy, Inc.; CONSOL Energy Inc. 20170158.................. G Quad-C Partners VIII, L.P.; Fusion Partners, LLC; Quad-C Partners VIII, L.P. 20170160.................. G Buckeye Partners, L.P.; Vitol Investment Partnership Limited; Buckeye Partners, L.P. 20170161.................. G Buckeye Partners, L.P.; Vitol Holding B.V.; Buckeye Partners, L.P. 20170168.................. G Quantum Energy Partners VI, LP; Freeport-McMoRan Inc.; Quantum Energy Partners VI, LP. 20170176.................. G Soohyung Kim; Twin River Worldwide Holdings, Inc.; Soohyung Kim. 20170177.................. G InPhi Corporation; ClariPhy Communications, Inc.; InPhi Corporation. 20170183.................. G Quad-C Partners VIII, L.P.; Wells Fargo & Company; Quad- C Partners VIII, L.P. 20170190.................. G Richard Webb; Kinder Morgan, Inc.; Richard Webb. 20170191.................. G Galanos Investments L.P.; KPS Special Situations Fund IV, LP; Galanos Investments L.P. ------------------------------------------------------------------------ 11/16/2016 ------------------------------------------------------------------------ 20170170.................. G Audax Private Equity Fund V- A, L.P.; Silver Oak Services Partners, L.P.; Audax Private Equity Fund V-A, L.P. 20170196.................. G PMHC II, Inc.; Eramet, S.A.; PMHC II, Inc. ------------------------------------------------------------------------ 11/17/2016 ------------------------------------------------------------------------ 20170129.................. G Amgen Inc.; Arrowhead Pharmaceuticals, Inc.; Amgen Inc. 20170164.................. G Daiichi Sankyo Co., Ltd.; Inspirion Delivery Technologies LLC; Daiichi Sankyo Co., Ltd. 20170167.................. G NextEra Energy, Inc.; Energy Future Holdings Corp.; NextEra Energy, Inc. 20170187.................. G Thomas A. Garrett; Cerberus Partners, L.P.; Thomas A. Garrett. 20170188.................. G Archrock Partners, L.P.; Archrock, Inc.; Archrock Partners, L.P. ------------------------------------------------------------------------ 11/18/2016 ------------------------------------------------------------------------ 20170097.................. G CBOE Holdings, Inc.; Bats Global Markets; CBOE Holdings, Inc. 20170102.................. G Joseph Mansueto; PitchBook Data, Inc.; Joseph Mansueto. 20170162.................. G Constellation Brands, Inc.; Eugenie Patri Sebastien EPS, SA; Constellation Brands, Inc. 20170163.................. G Constellation Brands, Inc.; Jorge Paulo Lemann; Constellation Brands, Inc. ------------------------------------------------------------------------ 11/21/2016 ------------------------------------------------------------------------ 20161824.................. G Blackfriars Corp.; Saudi Basic Industries Corp.; Blackfriars Corp. 20170209.................. G Odyssey Investment Partners Fund V, L.P.; HSM Tek, Inc.; Odyssey Investment Partners Fund V, L.P. 20170215.................. G SG Growth Partners III, LP; Weston Presidio V, L.P.; SG Growth Partners III, LP. 20170220.................. G Enviva Partners, LP; Riverstone/Carlyle Renewable and Alternative Energy Fund II,; Enviva Partners, LP. 20170225.................. G Sun Hydraulics Corporation; Frank W. Murphy III; Sun Hydraulics Corporation. 20170229.................. G Bain Capital Europe Fund IV, L.P.; ASF Park Acquisition LP; Bain Capital Europe Fund IV, L.P. 20170250.................. G Bed Bath & Beyond Inc.; Daniel R. Randolph; Bed Bath & Beyond Inc. ------------------------------------------------------------------------ 11/22/2016 ------------------------------------------------------------------------ 20170208.................. G Nestle S.A.; Aimmune Therapeutics, Inc.; Nestle S.A. ------------------------------------------------------------------------ 11/23/2016 ------------------------------------------------------------------------ 20170137.................. G Henderson Group plc; Janus Capital Group Inc.; Henderson Group plc. 20170173.................. G Huntington Ingalls Industries, Inc.; New Mountain Partners III, L.P.; Huntington Ingalls Industries, Inc. 20170174.................. G BW NHHC Co-Invest, L.P.; Wellspring Capital Partners V, L.P.; BW NHHC Co-Invest, L.P. 20170179.................. G Comcast Corporation; Racecar Holdings, LLC; Comcast Corporation. 20170180.................. G Steven E. Grosser; Racecar Holdings, LLC; Steven E. Grosser. 20170181.................. G Patrick J. McAdaragh; Racecar Holdings, LLC; Patrick J. McAdaragh. 20170217.................. G Synopsys, Inc.; LLR Equity Partners IV, L.P.; Synopsys, Inc. ------------------------------------------------------------------------ 11/28/2016 ------------------------------------------------------------------------ 20170113.................. G Micro Focus International plc; Hewlett Packard Enterprise Company; Micro Focus International plc. 20170136.................. G GTCR Fund XI/A LP; DPC Holdings, LLC; GTCR Fund XI/ A LP. 20170156.................. G Lintec Corporation; Platinum Equity Capital Evergreen Partners, L.P.; Lintec Corporation. 20170213.................. G HollyFrontier Corporation; Suncor Energy Inc.; HollyFrontier Corporation. 20170218.................. G SpeedCast International Limited; Harris Corporation; SpeedCast International Limited. 20170226.................. G The Kansai Electric Power Co., Inc.; Marubeni Corporation; The Kansai Electric Power Co., Inc. 20170228.................. G American Midstream Partners, LP; ArcLight Energy Partners Fund V, L.P.; American Midstream Partners, LP. 20170234.................. G Shangtex Holding Co. Ltd.; Dr. Henry Tan; Shangtex Holding Co. Ltd. 20170238.................. G JLL Partners Fund VII, L.P.; MedPlast Holdings, Inc.; JLL Partners Fund VII, L.P. 20170239.................. G Water Street Healthcare Partners III, L.P.; MedPlast Holdings, Inc.; Water Street Healthcare Partners III, L.P. 20170241.................. G Genstar Capital Partners VII, L.P.; David D. Morgan; Genstar Capital Partners VII, L.P. 20170246.................. G Blackstone Capital Partners VII L.P.; Team Health Holdings, Inc.; Blackstone Capital Partners VII L.P. 20170252.................. G Greencore Group plc; Charlesbank Equity Fund VII, Limited Partnership; Greencore Group plc. 20170260.................. G Leviton Manufacturing Co., Inc.; Allan B. Hubbard; Leviton Manufacturing Co., Inc. 20170264.................. G NuStar Energy L.P.; Martin Midstream Partners L.P.; NuStar Energy L.P. 20170266.................. G AP VIII DSB Holdings, L.P.; Ascension Health Alliance; AP VIII DSB Holdings, L.P. 20170268.................. G Kendall Automotive Group, Inc.; Gayle and James Chalfant; Kendall Automotive Group, Inc. [[Page 89946]] 20170269.................. G Kendall Automotive Group, Inc.; David and Lorraine Edmark; Kendall Automotive Group, Inc. 20170271.................. G Ascent Holdings, LLC; Fulcrum BioEnergy, Inc.; Ascent Holdings, LLC. 20170272.................. G JBG SMITH Properties; JBG/ Operating Partners, L.P.; JBG SMITH Properties. 20170280.................. G Blue Star Parent, L.P.; Ansira Holdings, LLC; Blue Star Parent, L.P. 20170289.................. G Antelope NewCo, Inc.; AlixPartners Holdings, LLP; Antelope NewCo, Inc. ------------------------------------------------------------------------ 11/30/2016 ------------------------------------------------------------------------ 20170159.................. G The Hearst Family Trust; GTCR Fund X/A LP; The Hearst Family Trust. 20170169.................. G Insight MB Parent LLC; MB Parent Holdings, LLC; Insight MB Parent LLC. 20170274.................. G Quintiles IMS Holdings, Inc.; Jon C. Anderson; Quintiles IMS Holdings, Inc. 20170279.................. G Calpine Corporation; NAPGS Holdco, LLC; Calpine Corporation. 20170281.................. G Adobe Systems Incorporated; TubeMogul, Inc.; Adobe Systems Incorporated. 20170284.................. G CENTRO ARTE SCIENZA E TECNOLOGIA S.R.L.; Nestle S. A.; CENTRO ARTE SCIENZA E TECNOLOGIA S.R.L. 20170296.................. G Bain Capital Fund XI, L.P.; Blue Nile, Inc.; Bain Capital Fund XI, L.P. 20170298.................. G AIPCF VI AIV Moly-Cop (Cayman), LP; Arrium Limited; AIPCF VI AIV Moly- Cop (Cayman), LP. 20170300.................. G Wind Point Partners, VIII-A, L.P.; Michael J. Baab; Wind Point Partners, VIII-A, L.P. 20170306.................. G AIM Marina Holdings, LLC; John D. Brewer, Jr. and Margaret S. Brewer; AIM Marina Holdings, LLC. ------------------------------------------------------------------------ FOR FURTHER INFORMATION CONTACT: Theresa Kingsberry Program Support Specialist, Federal Trade Commission Premerger Notification Office Bureau of Competition, Room CC-5301, Washington, DC 20024, (202) 326- 3100. By direction of the Commission. Donald S. Clark Secretary. [FR Doc. 2016-29771 Filed 12-12-16; 8:45 am] BILLING CODE 6750-01-P
![Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices 89943
compliance with those requirements consolidated assets of $10 billion or less 4. Other Federal rules. The Board has
will be one element of a broader to SLHCs. Until such time as the Board not identified any likely duplication,
qualitative and quantitative assessment adopts a final rule on the application of overlap and/or potential conflict
of capital adequacy.11 the RFI rating system to SLHCs, SLHCs between the proposed rule and any
Noncomplex SLHCs under $1 billion may refer to these letters for staff-level Federal rule.
will be assigned an abbreviated version guidance on the use of indicative 5. Significant alternatives to the
of the RFI rating system consistent with ratings. proposed revisions. The Board believes
the Board’s practice for BHCs outlined The Board invites comment on all that this proposal will not have a
in SR 13–21.12 An offsite review of the aspects of this proposal. significant economic impact on small
SLHC will be conducted upon receipt of banking organizations supervised by the
III. Regulatory Analysis
the lead depository institution’s report Board and therefore believes that there
of examination. The supervisory cycle Paperwork Reduction Act are no significant alternatives to this
will be determined by the examination There is no collection of information proposal that would reduce the
frequency of the lead depository required by this proposal that would be economic impact on small banking
institution and the SLHC will be subject to the Paperwork Reduction Act organizations supervised by the Board.
assigned only a risk management rating of 1995, 44 U.S.C. 3501 et seq. The Board solicits comment on any
and a composite rating. significant alternatives that would
Finally, elements of the RFI rating Regulatory Flexibility Analysis reduce the regulatory burden associated
system that are codified in the Board’s The Regulatory Flexibility Act (RFA) on small entities with this proposed
Bank Holding Company Supervision requires an agency to publish an initial rule.
Manual 13 and a policy letter issued by regulatory flexibility analysis with a
the staff of the Board’s Division of Solicitation of Comments on Use of
proposed rule or certify that the
Banking Supervision and Regulation Plain Language
proposed rule will not have a significant
will be revised if the proposal to fully economic impact on a substantial Section 722 of the Gramm-Leach-
apply the RFI system to certain SLHCs number of small entities. Based on its Bliley Act requires the Board to use
is finalized.14 analysis, and for the reasons stated plain language in all proposed and final
Assessment of Capital Adequacy for below, the rule would not have a rules published after January 1, 2000.
SLHCs That Receive Indicative Ratings significant economic impact on a The Board invites comment on how to
substantial number of small entities. make this proposed rule easier to
For SLHCs that would continue to Nevertheless, the Board is publishing an understand. For example:
receive an indicative rating under the initial regulatory flexibility analysis and • Has the Board organized the
RFI rating system, the Board proposes requests public comment on all aspects material to suit your needs? If not, how
that examiners, in the evaluation of of its analysis. The Board will, if could the proposal be more clearly
capital adequacy of an SLHC, consider necessary, conduct a final regulatory stated?
the risks inherent in the SLHC’s flexibility analysis after considering the • Are the requirements in the
activities and the ability of capital to comments received during the public proposal clearly stated? If not, how
absorb unanticipated losses, provide a comment period. could the proposal be more clearly
base for growth, and support the level 1. Statement of the need for, and stated?
and composition of the parent company objectives of, the proposed rule. The • Does the proposal contain technical
and subsidiaries’ debt. proposed rule would apply the same language or jargon that is not clear? If
Supervisory Guidance for SLHCs With supervisory rating system to SLHCs as so, what language requires clarification?
currently applies to bank holding • Would a different format (grouping
Less Than $10 Billion in Assets
companies. The RFI rating system is an and order of sections, use of headings,
In 2013, Board staff published several effective approach to communicating paragraphing) make the proposal easier
supervisory letters extending the use of supervisory expectations to SLHCs. This to understand? If so, what changes
the RFI rating system for and proposal furthers the Board’s goal of would make the proposal easier to
assignment of indicative ratings to ensuring that holding companies that understand?
SLHCs and extending the scope and control depository institutions are • Would more, but shorter, sections
frequency requirements for supervised subject to consistent standards and be better? If so, which sections should
holding companies with total supervisory programs. be changed?
2. Small entities affected by the • What else could the Board do to
11 See Sections 4060 and 4061 of the Bank
proposed rule. Under regulations issued make the proposal easier to understand?
Holding Company Supervision Manual;
Supervision and Regulation Letter 15–19 (December by the Small Business Administration, a By order of the Board of Governors of the
18, 2015), available at https:// small entity includes an SLHC with Federal Reserve System, December 8, 2016.
www.federalreserve.gov/bankinforeg/srletters/ total assets of $550 million or less. As Robert deV. Frierson,
sr1519.htm; Supervision and Regulation Letter 15– of October 31, 2016, there were
6 (April 6, 2015), available at https:// Secretary of the Board.
www.federalreserve.gov/bankinforeg/srletters/ approximately 157 small SLHCs. The [FR Doc. 2016–29891 Filed 12–12–16; 8:45 am]
sr1506.htm; Supervision and Regulation Letter 09– proposed rule will not have a significant BILLING CODE 6210–01–P
04 (February 24, 2009, revised December 21, 2015), economic impact on the entities that it
available at http://www.federalreserve.gov/ affects because the proposal does not
boarddocs/srletters/2009/sr0904.htm.
impose any recordkeeping, reporting, or
12 Supervision and Regulation Letter 13–21
FEDERAL TRADE COMMISSION
pmangrum on DSK3GDR082PROD with NOTICES
(December 17, 2013), available at https:// compliance requirements. The Board
www.federalreserve.gov/bankinforeg/srletters/ invites comment on the effect of the Granting of Request for Early
sr1321.htm. proposed rule on small entities. Termination of the Waiting Period
13 Available at http://www.federalreserve.gov/
3. Recordkeeping, reporting, and Under the Premerger Notification
boarddocs/supmanual/supervision_bhc.htm. compliance requirements. The proposed
14 See Supervision and Regulation Letter 04–18 Rules
(December 6, 2014), available at http://
rule would not impose any
www.federalreserve.gov/boarddocs/srletters/2004/ recordkeeping, reporting, or compliance Section 7A of the Clayton Act, 15
sr0418.htm. requirements. U.S.C. 18a, as added by Title II of the
VerDate Sep<11>2014 15:08 Dec 12, 2016 Jkt 241001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/81_FR_90182/page/1.svg)
![89946 Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices
EARLY TERMINATIONS GRANTED NOVEMBER 1, 2016 THRU NOVEMBER 30, 2016—Continued
20170269 G Kendall Automotive Group, Inc.; David and Lorraine Edmark; Kendall Automotive Group, Inc.
20170271 G Ascent Holdings, LLC; Fulcrum BioEnergy, Inc.; Ascent Holdings, LLC.
20170272 G JBG SMITH Properties; JBG/Operating Partners, L.P.; JBG SMITH Properties.
20170280 G Blue Star Parent, L.P.; Ansira Holdings, LLC; Blue Star Parent, L.P.
20170289 G Antelope NewCo, Inc.; AlixPartners Holdings, LLP; Antelope NewCo, Inc.
11/30/2016
20170159 G The Hearst Family Trust; GTCR Fund X/A LP; The Hearst Family Trust.
20170169 G Insight MB Parent LLC; MB Parent Holdings, LLC; Insight MB Parent LLC.
20170274 G Quintiles IMS Holdings, Inc.; Jon C. Anderson; Quintiles IMS Holdings, Inc.
20170279 G Calpine Corporation; NAPGS Holdco, LLC; Calpine Corporation.
20170281 G Adobe Systems Incorporated; TubeMogul, Inc.; Adobe Systems Incorporated.
20170284 G CENTRO ARTE SCIENZA E TECNOLOGIA S.R.L.; Nestle S. A.; CENTRO ARTE SCIENZA E TECNOLOGIA S.R.L.
20170296 G Bain Capital Fund XI, L.P.; Blue Nile, Inc.; Bain Capital Fund XI, L.P.
20170298 G AIPCF VI AIV Moly-Cop (Cayman), LP; Arrium Limited; AIPCF VI AIV Moly-Cop (Cayman), LP.
20170300 G Wind Point Partners, VIII-A, L.P.; Michael J. Baab; Wind Point Partners, VIII-A, L.P.
20170306 G AIM Marina Holdings, LLC; John D. Brewer, Jr. and Margaret S. Brewer; AIM Marina Holdings, LLC.
FOR FURTHER INFORMATION CONTACT: extension acted with due diligence • For written/paper comments
Theresa Kingsberry Program Support during the regulatory review period by submitted to the Division of Dockets
Specialist, Federal Trade Commission June 12, 2017. See ‘‘Petitions’’ in the Management, FDA will post your
Premerger Notification Office Bureau of SUPPLEMENTARY INFORMATION section for comment, as well as any attachments,
Competition, Room CC–5301, more information. except for information submitted,
Washington, DC 20024, (202) 326–3100. ADDRESSES: You may submit comments marked and identified, as confidential,
By direction of the Commission. as follows: if submitted as detailed in
Donald S. Clark ‘‘Instructions.’’
Electronic Submissions Instructions: All submissions received
Secretary.
Submit electronic comments in the must include the Docket No. FDA–
[FR Doc. 2016–29771 Filed 12–12–16; 8:45 am]
following way: 2016–E–0625 for ‘‘Determination of
BILLING CODE 6750–01–P
• Federal eRulemaking Portal: Regulatory Review Period for Purposes
https://www.regulations.gov. Follow the of Patent Extension; NUCALA.’’
instructions for submitting comments. Received comments will be placed in
DEPARTMENT OF HEALTH AND the docket and, except for those
Comments submitted electronically,
HUMAN SERVICES submitted as ‘‘Confidential
including attachments, to https://
Food and Drug Administration www.regulations.gov will be posted to Submissions,’’ publicly viewable at
the docket unchanged. Because your https://www.regulations.gov or at the
[Docket No. FDA–2016–E–0625] comment will be made public, you are Division of Dockets Management
solely responsible for ensuring that your between 9 a.m. and 4 p.m., Monday
Determination of Regulatory Review through Friday.
comment does not include any
Period for Purposes of Patent • Confidential Submissions—To
confidential information that you or a
Extension; NUCALA submit a comment with confidential
third party may not wish to be posted,
AGENCY: Food and Drug Administration, such as medical information, your or information that you do not wish to be
HHS. anyone else’s Social Security number, or made publicly available, submit your
ACTION: Notice. confidential business information, such comments only as a written/paper
as a manufacturing process. Please note submission. You should submit two
SUMMARY: The Food and Drug that if you include your name, contact copies total. One copy will include the
Administration (FDA) has determined information, or other information that information you claim to be confidential
the regulatory review period for identifies you in the body of your with a heading or cover note that states
NUCALA and is publishing this notice comments, that information will be ‘‘THIS DOCUMENT CONTAINS
of that determination as required by posted on https://www.regulations.gov. CONFIDENTIAL INFORMATION.’’ The
law. FDA has made the determination • If you want to submit a comment Agency will review this copy, including
because of the submission of an with confidential information that you the claimed confidential information, in
application to the Director of the U.S. do not wish to be made available to the its consideration of comments. The
Patent and Trademark Office (USPTO), public, submit the comment as a second copy, which will have the
Department of Commerce, for the written/paper submission and in the claimed confidential information
extension of a patent which claims that manner detailed (see ‘‘Written/Paper redacted/blacked out, will be available
human biological product. Submissions’’ and ‘‘Instructions’’). for public viewing and posted on
DATES: Anyone with knowledge that any https://www.regulations.gov. Submit
Written/Paper Submissions
pmangrum on DSK3GDR082PROD with NOTICES
of the dates as published (see the both copies to the Division of Dockets
SUPPLEMENTARY INFORMATION section) are Submit written/paper submissions as Management. If you do not wish your
incorrect may submit either electronic follows: name and contact information to be
or written comments and ask for a • Mail/Hand delivery/Courier (for made publicly available, you can
redetermination by February 13, 2017. written/paper submissions): Division of provide this information on the cover
Furthermore, any interested person may Dockets Management (HFA–305), Food sheet and not in the body of your
petition FDA for a determination and Drug Administration, 5630 Fishers comments and you must identify this
regarding whether the applicant for Lane, Rm. 1061, Rockville, MD 20852. information as ‘‘confidential.’’ Any
VerDate Sep<11>2014 15:08 Dec 12, 2016 Jkt 241001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/81_FR_90182/page/4.svg)
Document Created: 2016-12-13 02:44:57
Document Modified: 2016-12-13 02:44:57
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Contact | Theresa Kingsberry Program Support Specialist, Federal Trade Commission Premerger Notification Office Bureau of Competition, Room CC-5301, Washington, DC 20024, (202) 326- 3100. | |
| FR Citation | 81 FR 89943 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR